Distribuzione geografica
Continente #
NA - Nord America 9.823
EU - Europa 6.034
AS - Asia 2.065
AF - Africa 394
Continente sconosciuto - Info sul continente non disponibili 15
OC - Oceania 3
Totale 18.334
Nazione #
US - Stati Uniti d'America 9.180
IE - Irlanda 2.156
CN - Cina 1.799
UA - Ucraina 1.790
CA - Canada 642
IT - Italia 634
RU - Federazione Russa 500
CI - Costa d'Avorio 309
SE - Svezia 281
GR - Grecia 186
VN - Vietnam 167
DE - Germania 112
GB - Regno Unito 83
CH - Svizzera 60
SN - Senegal 59
FR - Francia 58
AT - Austria 35
IN - India 32
UZ - Uzbekistan 32
CZ - Repubblica Ceca 31
NL - Olanda 31
BE - Belgio 26
NG - Nigeria 24
PL - Polonia 21
EU - Europa 15
JP - Giappone 10
LB - Libano 9
BG - Bulgaria 8
FI - Finlandia 4
ES - Italia 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
GE - Georgia 2
HK - Hong Kong 2
MY - Malesia 2
RO - Romania 2
TR - Turchia 2
BN - Brunei Darussalam 1
BY - Bielorussia 1
BZ - Belize 1
DK - Danimarca 1
IR - Iran 1
IS - Islanda 1
KE - Kenya 1
KR - Corea 1
LU - Lussemburgo 1
MA - Marocco 1
MD - Moldavia 1
MK - Macedonia 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
SG - Singapore 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 18.334
Città #
Jacksonville 2.375
Dublin 2.154
Chandler 1.400
Nanjing 640
Houston 619
Lawrence 542
Andover 537
Cambridge 535
Toronto 498
Des Moines 377
Boardman 338
Catania 329
Abidjan 309
Ashburn 270
San Mateo 230
Nanchang 227
Wilmington 186
Hebei 177
Shenyang 158
Dong Ket 143
Athens 136
Ottawa 135
Jiaxing 115
Saint Petersburg 114
Tianjin 112
Changsha 90
Dakar 59
Washington 57
Beijing 45
Bremen 43
Moscow 43
Norwalk 39
Hangzhou 37
Kunming 34
Jinan 30
Ningbo 29
Brussels 26
Abuja 24
Den Haag 24
Hanoi 24
Liberty Lake 24
Pune 24
Brno 23
Zhengzhou 22
Gravina di Catania 18
Ann Arbor 17
Edinburgh 16
Taizhou 16
Frankfurt Am Main 14
Milan 13
Pozzo Di Gotto 13
Falls Church 12
Manduria 12
Padova 11
Aigaleo 10
Changchun 10
Redwood City 10
Hanover 9
Kiev 9
Lausanne 9
Guangzhou 8
Rome 8
Acireale 7
Lanzhou 7
Princeton 7
Tappahannock 7
Fairfield 6
Ludwigshafen 6
Palermo 6
Providence 6
Canicattini Bagni 5
Civitavecchia 5
Maletto 5
Mascalucia 5
Scicli 5
Shanghai 5
Stein 5
Stockholm 5
Casarano 4
Fuzhou 4
Helsinki 4
Woodbridge 4
Bisceglie 3
Boydton 3
Chicago 3
Dearborn 3
Groningen 3
Lisbon 3
Manfredonia 3
Pavia 3
Piraeus 3
Redmond 3
Taranto 3
Tokyo 3
Amsterdam 2
Aprilia 2
Atlanta 2
Augusta 2
Caltanissetta 2
Cedar Park 2
Totale 13.724
Nome #
Novel oral anticoagulants versus warfarin in non-valvular atrial fibrillation: A meta-analysis of 50,578 patients 488
Neoatherosclerosis as the cause of late failure of a bioresorbable vascular scaffold 199
Incorporating glomerular filtration rate or creatinine clearance by the modification of diet in renal disease equation or the Cockcroft-Gault equations to improve the global accuracy of the Age, Creatinine, Ejection Fraction [ACEF] score in patients undergoing percutaneous coronary intervention 106
1-Year Outcomes of Everolimus-Eluting Bioresorbable Scaffolds versus Everolimus-Eluting Stents: a Propensity Matched Comparison of the GHOST-EU and XIENCE V USA Registries 93
A Risk Model for Prediction of One-Year Mortality in Patients Undergoing MitraClip Implantation 80
Miocardio non compattato del ventricolo sinistro e aneurisma del setto interatriale con difetto. Associazione casuale? 65
Predictive Accuracy of CHA2DS2-VASc and HAS-BLED Scores In Patients Without Atrial Fibrillation Undergoing Percutaneous Coronary Intervention And Discharged On Dual Antiplatelet Therapy 61
Prevalence of renal artery stenosis in patients undergoing cardiac catheterization 60
Anatomical features and management of bioresorbable vascular scaffolds failure: A case series from the GHOST registry. 59
Quality of life assessment after percutaneous aortic valve implantation 56
Transcatheter aortic valve implantation in 2017: state of the art 56
Antithrombotic Therapy for Secondary Prevention in Patients with Cerebrovascular Disease 55
Clinical implication of different plaque distribution patterns in distal left main coronary artery 54
Standardised Definitions of Structural Deterioration and Valve Failure in Assessing Long-Term Durability of Transcatheter and Surgical Aortic Bioprosthetic Valves: A Consensus Statement from The European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 54
Clinical decision making in left main revascularization: the past, the present and the future 53
Cigarette Smoking is Associated with a Dose-Response Effect in Clopidogrel Treated Patients with Diabetes Mellitus and Coronary Artery Disease: Results of a Pharmacodynamic Study 53
Vascular response and healing profile of everolimus-eluting bioresorbable vascular scaffolds for percutaneous treatment of chronic total coronary occlusions: A one-year optical coherence tomography analysis from the GHOST-CTO registry 53
Temporal patterns of early neointimal strut coverage of the CATANIA stent compared with drug eluting stents and bare metal stent: the Rapid Evaluation of Vessel Healing after Angioplasty (REVEAL) trial 52
[Management of severe stenosis controversies and promises] 52
Diabetes mellitus: the scary killer haunting silently 51
Intraoperative defibrillation threshold testing durino implantable cardioverter-defibrillator insertion: Do we really need it? 51
Local delivery versus intracoronary infusion of abciximab in patients with acute coronary syndromes 51
Is the metallic stent a safe treatment for bioresorbable scaffold failure? Insights from optical coherence tomography 51
Very Late Outcomes of Drug-Eluting Stents: The "Catch-Down" Phenomenon 51
Antithrombotic Therapy in Patients with Chronic Kidney Disease 50
Pretreatment with Antiplatelet Agents in the Setting of Percutaneous Coronary Intervention: When and Which Drugs? 50
Effects of Cangrelor in Coronary Artery Disease Patients With and Without Diabetes Mellitus: An In Vitro Pharmacodynamic Investigation 50
Long-term bleeding events in patients with prolonged dual antiplatelet therapy after DES implantation 50
EuroSCORE refines the predictive ability of SYNTAX score in patients undergoing left main percutaneous coronary intervention 49
Reply: Validity of Randomized Trials Comparing Radial Versus Femoral Access in Acute Coronary Syndrome 49
Recent acquisitions and advances in the knowledge of coronary flow disturbances after percutaneous coronary intervention 49
Impact of race and gender on antithrombotic therapy 49
The inflammatory abdominal aortic aneurysm and coronary artery disease. Case report and review 49
Association of Tricuspid Regurgitation With Clinical and Echocardiographic Outcomes After Percutaneous Mitral Valve Repair With the MitraClip System: Thirty-Day and Twelve-Month Follow-up From the GRASP Registry 49
Morphine is associated with a delayed activity of oral antiplatelet agents in patients with ST-elevation acute myocardial infarction undergoing primary PCI 49
Pre-dilation, Sizing and Post-dilation scoring in patients undergoing everolimus-eluting bioresorbable scaffolds implantation for prediction of cardiac adverse events: development and internal validation of the PSP score 49
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registry. 49
Spontaneous coronary artery dissection 48
Upcoming TAVI trials: rationale, design and likely impact on clinical practice 48
Three-Dimensional Angle Assessment and Plaque Distribution Classification in Left Main Disease: Impact of Geometry on Outcome 48
Association of tricuspid regurgitation with clinical and echocardiographic outcomes after percutaneous mitral valve repair with the MitraClip System: 30-day and 12-month follow-up from the GRASP Registry 48
The treatment of coronary bifurcation lesions with bioresorbable vascular scaffolds 48
Feasibility and Predictors of Early Discharge After Percutaneous Edge-to-Edge Mitral Valve Repair 48
Optimal P2Y12 inhibitor for primary PCI in STEMI: Network meta-analysis in the data-fre zone. Do you believe in magic? 48
Fate of Non-Culprit Plaques in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention Followed by Statin Therapy: A Serial Optical Coherence Tomography Analysis From the OCTAVIA Study 48
A comparison between Endeavor and Endeavor Resolute drug-eluting stents: outcome at six months follow up 48
Tailoring duration of DAPT with risk scores 47
Early, late and very late incidence of bioresorbable scaffold thrombosis: a systematic review and meta-analysis of randomized clinical trials and observational studies 47
Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery in Left Main Coronary Artery Disease: a Meta-Analysis of Randomized Clinical Data 47
Emerging strategies for rapid reversal of anticoagulation in patients undergoing catheter-based interventions: aptamers enter the RADAR 47
New-onset coronary aneurism and late-acquired incomplete scaffold apposition after full polymer jacket of a chronic total occlusion with bioresorbable scaffolds 47
Coronary revascularization strategies in patients with multivessel disease: is it all about diabetes? 47
Acute Kidney Injury With the RenalGuard System in Patients Undergoing Transcatheter Aortic Valve Replacement: The PROTECT-TAVI Trial (PROphylactic effecT of furosEmide-induCed diuresis with matched isotonic intravenous hydraTion in Transcatheter Aortic Valve Implantation) 47
Acute Left Atrial Spontaneous Echo Contrast and Suspicious Thrombus Formation Following Mitral Regurgitation Reduction With The MitraClip System 47
Early discharge in acute myocardial infarction after clinical and angiographic risk assessment 46
Unraveling the EXCEL: Promises and Challenges of the Next Trial of Left Main Percutaneous Coronary Intervention 46
Does the SYNTAX score get on your nerves? Practical considerations on how and when avoiding it to maximize its usefulness with no waste of time 46
Mechanisms, Pathophysiology, and Clinical Aspects of Incomplete Stent Apposition 46
Usefulness of 3D OCT to Diagnose a Noncircumferential Open-Cell Stent Fracture 46
Reply: plaque rupture in stable coronary artery disease 46
Haemostatic Profiles Assessed by Thromboelastography in Patients with End-Stage Renal Disease 46
Bivalirudin For Acute Coronary Syndromes: Premises, Promises and Doubts 46
Bioresorbable vascular scaffold in patients with complex coronary artery disease. 46
Bioresorbable Everolimus-Eluting Vascular Scaffold for Long Coronary Lesions: A Subanalysis of the International, Multicenter GHOST- EU Registry - Reply 46
A focused update on emerging prognostic determinants in distal left main percutaneous coronary intervention 46
Progresses in interventional cardiology: focus on patent foramen ovale, coronary intervention, antithrombotic pharmacology, and more 46
Update on clinical evidence (Part II): a summary of the main post market studies 46
Volumetric Assessment of Lesion Severity with Optical Coherence Tomography: Relationship with Fractional Flow Reserve 46
Long term outcome of patients with chronic total occlusions: the value of monitoring percutaneous coronary intervention by non-invasive imaging 46
Guideline-driven versus non-guideline driven approach for left main coronary artery revascularization: the Appraise a customized strategy for left main revascularization (CUSTOMIZE) study 46
Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA) 46
The Sicilian Drug-eluting Stent Registry - Risk-benefits and Cost-effectiveness Analyses of Drug-eluting Stents versus Bare-metal Stents 45
Antiplatelet Therapy: New Pharmacological Agents and Changing Paradigms 45
Radial access reduces mortality in patients with acute coronary syndromes. Results from an updated trial sequential analysis of randomized trials 45
Management issues of chronic therapy with non-vitamin K oral anticolagulants or antiplatelet agents: different or alike? 45
The optimal pharmacological formula for percutaneous coronary intervention 45
Bridging antiplatelet therapy in patients requiring cardiac and non-cardiac surgery: from bench to bedside 45
Antiplatelet and anticoagulant therapy in elderly patients 45
Percutaneous mitral valve repair with the MitraClip system: acute results from a real world setting 45
Lo studio PRAMI 45
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC) 45
A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score 45
Head-to-head comparison of early vessel healing by optical coherence tomography after implantation of different stents in the same patient 45
Response to: “SYNTAX score and left main stenting: do we need clinical variables to predict outcomes?” 44
Long-Term Follow-Up after Drug Eluting Stent Implantation in Left Main Trifurcations 44
Functional profile of the platelet P2Y12 receptor signaling pathway in patients with diabetes mellitus and coronary artery disease 44
Routine versus selective coronary artery bypass for left main coronary artery revascularization: The appraise a customized strategy for left main revascularization (CUSTOMIZE) study 44
Strategies and Outcomes of Repeat Mitral Valve Interventions After Failed MitraClip Therapy 44
Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System 44
A Multidisciplinary Approach on the Perioperative Antithrombotic Management of Patients With Coronary Stents Undergoing Surgery: Surgery After Stenting 2 44
Early and mid term clinical outcomes with the CATANIA coronary stent system versus bare metal stents in patients with coronary artery disease 44
Incidence of Long-Term Structural Valve Dysfunction and Bioprosthetic Valve Failure After Transcatheter Aortic Valve Replacement 44
Standardized definitions of structural deterioration and valve failure in assessing long-term durability of transcatheter and surgical aortic bioprosthetic valves: a consensus statement from the European Association of Percutaneous Cardiovascular Interventions (EAPCI) endorsed by the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 44
Effect of post-procedural evidence-based therapy on 2-year prognosis after transcatheter mitral valve repair 43
Management of Antiplatelet Therapy in Patients with Coronary Artery Disease Requiring Cardiac and Noncardiac Surgery 43
Cyphering the mechanism of late failure of bioresorbable vascular scaffolds in percutaneous coronary intervention of the left main coronary artery 43
Management of implant failure during transcatheter aortic valve implantation 43
Percutaneous Coronary Intervention With Everolimus-Eluting Bioresorbable Vascular Scaffolds In Routine Clinical Practice: Early and Mid-Term Outcomes From The European Multicenter GHOST-EU Registry 43
Revisiting Sex Equality With Transcatheter Aortic Valve Replacement Outcomes: A Collaborative, Patient-Level Meta-Analysis of 11,310 Patients 43
Totale 5.523
Categoria #
all - tutte 51.968
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.968

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019758 0 0 0 0 0 497 55 3 9 26 35 133
2019/20203.624 1.300 236 319 154 361 47 486 6 235 48 285 147
2020/20213.251 12 231 498 8 834 113 501 6 269 24 525 230
2021/20223.809 500 586 11 51 626 12 565 100 335 5 84 934
2022/20235.514 552 69 41 361 688 1.004 11 908 1.594 35 180 71
2023/20241.272 130 503 114 203 143 179 0 0 0 0 0 0
Totale 19.069